China's blue-chips closed lower on Tuesday after U.S. drugmaker Moderna set off fresh alarm bells about the Omicron variant, while data showed China's services sector grew at a slightly slower pace amid regional outbreaks of COVID-19 cases.
The blue-chip CSI300 index closed 0.4% lower at 4,832.03, while the Shanghai Composite Index...
